.AstraZeneca has discussed an early examine the efficiency of its own in-house antibody-drug conjuga...
.After declaring a phase 3 launch based upon good midstage end results, iTeos and GSK are actually e...
.The FDA should be actually more available and also joint to let loose a rise in commendations of un...
.It's an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therapeutics a...
.Atea Pharmaceuticals' antiviral has fallen short an additional COVID-19 test, yet the biotech still...
.Neurocrine Biosciences' schizophrenia system pivot has actually failed. The biotech was actually un...
.Sanofi has made an overdue access to the radioligand party, paying 100 thousand euros ($ 110 thousa...
.After F2G's initial attempt to obtain a brand-new lesson of antifungal to market was actually hinde...
.Moderna has actually vowed to reduce R&D spending by $1.1 billion through 2027. The choice to sh...
.Simply 4 months after Sanofi bet $80 million in beforehand cash on Pivot Therapies' losmapimod, the...